Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

5-ARI therapy may help prevent prostate cancer progression.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.